Nivat Medical Device Ltd Advances Hybrid Heart Valve Capsule Development
Nivat Medical Device Ltd is developing a hybrid heart valve capsule, with laboratory and animal trials set to begin by the end of 2026. The innovation aims to resolve limitations of current valve technologies, potentially attracting partnerships and investments.
Theia Market Signal Identification - AI Assisted
Nivat Medical Device Ltd is progressing with a hybrid heart valve capsule to tackle issues present in existing technologies. Founded by Nir Sadan and Dr. Yoav Turgeman, the company aims to start laboratory and animal trials by the end of 2026.
Despite operational challenges from the COVID-19 pandemic and regional conflicts, Nivat maintains a focused R&D strategy. This could lead to significant advancements in medical applications and may enhance the company's position in attracting future investments.
Comments